Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Their diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVIDâ„¢), anthrax (NasoShieldâ„¢) and influenza (NasoVAXâ„¢); an intranasal immune modulating therapeutic for COVID-19 (T-COVIDâ„¢); and next generation peptide
…More therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcellâ„¢).